Journal Title
CLIMACTERIC

CLIMACTERIC

ISSN / eISSN
1369-7137 / 1473-0804
Aims and Scope
Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women.
Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments.

The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.
Subject Area

OBSTETRICS & GYNECOLOGY

CiteScore
5.50 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Obstetrics and Gynecology Q1 #44/209
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
OBSTETRICS & GYNECOLOGY Q1
H-index
62
Country/Area of Publication
ENGLAND
Publisher
Taylor and Francis Ltd.
Publication Frequency
Quarterly
Year Publication Started
1998
Annual Article Volume
88
Open Access
NO
Contact
Informa plc ("Informa") Mortimer House, 37-41 Mortimer Street, London, W1T 3JH

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started